FeesSafety
Pluang+

Gate adds 19 Taiwan stocks for trading with USDT, no TWD conversion needed

04 Nov 2026, 15:50 WIB
Tokenpost
View Source
Bullish
Gate adds 19 Taiwan stocks for trading with USDT, no TWD conversion needed

Gate has expanded its stock trading service by adding 19 shares from the Taiwan Stock Exchange, allowing users to trade directly with Tether (USDT) without converting to New Taiwan dollars first. This includes major companies in semiconductors, AI, electronics manufacturing, and finance like TSMC and MediaTek. Trading hours align with Taiwan's regular market session, and users can manage holdings and view records using existing Gate accounts. This move broadens Gate's global stock service, now covering over 12,800 stocks across multiple countries, and complements its recent Gate Money service that integrates crypto, stocks, and payments.

Gate's addition of 19 Taiwan stocks to its Tether (USDT) trading service is noted here with Pluang market data as of Nov 04, 2026 20:22 WIB. Of 50 major cryptocurrencies priced on Pluang, 28 rose and 20 fell today. Notable movers include BAL (Balancer) at Rp16.297 with a 1-day change of +11.14%, BAT (Basic Attention Token) at Rp2.507 with +9.21%, and EOS (EOS.IO) at Rp12.649 with +8.13%.

More News

Good Life Meds must stop unproven health and personalization claims for compounded Tirzepatide+ products.

Good Life Meds must stop unproven health and personalization claims for compounded Tirzepatide+ products.

The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...

Market News
Bearish
26 minutes ago
Moleculin's Annamycin shows promising remission rates in AML trial, data to be presented at ASH 2026.

Moleculin's Annamycin shows promising remission rates in AML trial, data to be presented at ASH 2026.

Moleculin Biotech announced that interim results from its Phase 2/3 trial of Annamycin for relapsed or refractory acute myeloid leukemia (AML) will be presented at the 2026 ASH Annual Meeting. The trial showed remission rates of 43% and 36% in two An...

Company Fundamentals
Bullish
26 minutes ago
ANZ dental implants market to grow 5% CAGR, reaching $393M by 2033 driven by aging population and prosthetic demand

ANZ dental implants market to grow 5% CAGR, reaching $393M by 2033 driven by aging population and prosthetic demand

The Australia and New Zealand (ANZ) dental implants market, valued at $266 million in 2025, is projected to grow at a 5% CAGR to $393 million by 2033. Growth is driven by increasing demand for oral rehabilitation and prosthetic dentistry, especially ...

Market News
Bullish
26 minutes ago
New study shows Asgard's tech induces cancer-fighting structures in tumors, boosting therapy success across 7 cancer types.

New study shows Asgard's tech induces cancer-fighting structures in tumors, boosting therapy success across 7 cancer types.

Asgard Therapeutics published a study in Immunity demonstrating its technology can reprogram tumor cells into dendritic cells, inducing cancer-fighting tertiary lymphoid structures (imgTLSs) across seven tumor types. This tumor-agnostic approach led ...

Others
Bullish
26 minutes ago
Cap expands onchain credit marketplace to finance film production without tokenizing assets

Cap expands onchain credit marketplace to finance film production without tokenizing assets

Cap, an onchain credit marketplace, is expanding into film and media financing by providing funding for the upcoming film Wake. This deal uses advances against anticipated film production tax credits, showing how Cap's underwriting model supports spe...

Market News
Bullish
26 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App